These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 742571)

  • 1. The immunologic response to tobacco antigens in smokers: II. Specific precipitins against tobacco antigens in the serum of smokers suffering from coronary heart disease.
    Romanśki B; Broda S; Swiatkowski M
    Allergol Immunopathol (Madr); 1978; 6(5):383-90. PubMed ID: 742571
    [No Abstract]   [Full Text] [Related]  

  • 2. The immunologic response to tobacco antigens in smokers. III. Type III hypersensitivity skin reactions and specific serum precipitins to four different tobacco extracts in patients suffering from coronary artery disease.
    Romański B; Broda S; Swiatkowski M; Zbikowska M
    Allergol Immunopathol (Madr); 1979; 7(3):187-96. PubMed ID: 474326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunological response to tobacco antigens in the smoker. I. Specific precipitins against tobacco antigens in the serum of healthy cigarette smokers.
    Romanski B; Broda S
    Allergol Immunopathol (Madr); 1977; 5(6):659-62. PubMed ID: 610410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunologic response to tobacco antigens in smokers. V. Plasma concentrations of immunoglobulin and some complement components in tobacco hypersensitive patients suffering from coronary artery disease.
    Romański B; Broda S; Swiatkowski M; Zbikowska-Gotz M
    Allergol Immunopathol (Madr); 1981; 9(6):487-94. PubMed ID: 7340473
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influence of tobacco smoke on the morbidity of non-smokers].
    Schievelbein H
    Internist (Berl); 1973 May; 14(5):236-43. PubMed ID: 4585207
    [No Abstract]   [Full Text] [Related]  

  • 6. The immunologic response to tobacco antigens in smokers. VI. Phagocytosis of tobacco antigens by peripheral blood polymorphonuclear leucocytes studied by immunofluorescence.
    Romanski B; Zbikowska-Götz M; Kakol J; Sinkiewicz W
    Allergol Immunopathol (Madr); 1984; 12(4):321-7. PubMed ID: 6391125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic study of Nicotiana tabacum and research on precipitins against tobacco antigens in the serum of smokers and nonsmokers.
    Panayotopoulos S; Gotsis N; Papazoglou N; Concouris L
    Allergol Immunopathol (Madr); 1974; 2(2):111-4. PubMed ID: 4850605
    [No Abstract]   [Full Text] [Related]  

  • 8. The immunologic response to tobacco antigens in smokers. IV. Effect of heparin, aspirin, promethazine and prednisone.
    Romanski B; Kurek M; Sinkiewicz W; Swiatkowski M; Zbikowska-Gotz M
    Allergol Immunopathol (Madr); 1981; 9(5):411-6. PubMed ID: 7349027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Menopause and myocardial infarction].
    Blanc JJ; Boschat J; Morin JF; Clavier J; Penther P
    Nouv Presse Med; 1974 Oct; 3(34):2173-5. PubMed ID: 4438068
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intracutaneous tests using tobacco extracts and cardiovascular disease. 1. With special reference to coronary arteriosclerosis].
    Kinoshita S; Sato N; Saito N; Nishida K; Dake F
    Arerugi; 1967 Nov; 16(11):729-33. PubMed ID: 5594586
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunoglobulin A and tobacco antigens in patients with pneumopathy].
    Martínez RD; Moreno A
    Rev Alerg; 1992; 39(5):106-12. PubMed ID: 1462105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing views of the spectrum and management of atherosclerotic coronary artery disease.
    Kossmann CE
    Adv Intern Med; 1976; 21():363-89. PubMed ID: 766590
    [No Abstract]   [Full Text] [Related]  

  • 13. Tobacco allergy in cardiovascular disease: a review.
    Harkavy J
    Ann Allergy; 1968 Aug; 26(8):447-59. PubMed ID: 4877583
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tobacco and coronary cardiopathy. Its action in the long-term development in the patient who has suffered a myocardial infarct].
    Paras Chavero E; Mercado Contreras E; Quintero Novella A
    Arch Inst Cardiol Mex; 1970; 40(2):128-34. PubMed ID: 5489735
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of the risk of ischemic heart disease in the smoker. Relation to the percentage of carboxyhemoglobin as a function of tobacco habits].
    Claude JR; Lellouch J; Truhaut R
    Ann Pharm Fr; 1977; 35(3-4):85-9. PubMed ID: 869477
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of tobacco on the immune system. I. Production of the cell migration inhibition factor in the presence of tobacco extract as an antigen in smokers and non-smokers].
    Bernal-Madrazo MA; Ham-Carrillo MS
    Gac Med Mex; 1981 Oct; 117(10):412-4. PubMed ID: 7044867
    [No Abstract]   [Full Text] [Related]  

  • 17. [Tobacco and health].
    Nogue MR
    Vie Med Can Fr; 1973 Jan; 2(1):21-32. PubMed ID: 4711742
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum precipitins against microbes in mouldy hay with respect to age, sex, atopy, and smoking of farmers.
    Terho EO; Husman K; Vohlonen I; Mäntyjärvi RA
    Eur J Respir Dis Suppl; 1987; 152():115-21. PubMed ID: 3499339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of smoking in the occurrence of ischemic heart disease].
    Neverov IV; Evtushenko GN
    Sov Med; 1981; (10):60-4. PubMed ID: 7031906
    [No Abstract]   [Full Text] [Related]  

  • 20. [Circulating myocardial antigens in patients with ischemic heart disease].
    Mel'nik IA; Baranovskiĭ PV; Liubetskiĭ AS; Nesterenko LI
    Vrach Delo; 1985 Feb; (2):65-7. PubMed ID: 3992990
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.